[1] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中国实用内科杂志, 2018, 38(4):34-86. [2] KOSTOWSKA-KAPŁON U, SZPRYNGER K, SZCZEPAŃSKA M. Multiorgan dysfunction syndrome complicating hyperosmolar hyperglycemic syndrome as the primary feature of juvenile diabetes[J]. Pol Merkur Lekarski, 2000, 8(46):293-294. [3] 赵欢, 石雪, 王爱平,等. 糖尿病高渗性昏迷合并酮症酸中毒致急性重症胰腺炎及多器官功能障碍综合征1例报告及文献复习[J]. 中国实验诊断学, 2016, 20(1):147-148. [4] HUANG X D,ZHAO W,ZHANG L X,et al.The role of complement activation in rhabdomyolysis-induced acute kidney injury[J]. PLoS One,2018,13(2):e0192361. [5] 李萍, 孔媛, 梁琳琅. 高血糖高渗状态和糖尿病酮症酸中毒合并横纹肌溶解综合征1例[J]. 内科急危重症杂志, 2019,25(3):261-264. [6] 康静, 石雪, 陈琰,等. 糖尿病高渗性昏迷合并酮症酸中毒致多器官功能障碍综合征及下丘脑综合征1例[J]. 中国现代医学杂志, 2019, 29(7):125-126. [7] PASQUEL F J, UMPIERREZ G E. Hyperosmolar hyperglycemic state:A historic review of the clinical presentation, diagnosis, and treatment[J]. Diabetes Care, 2014, 37(11):3124-3131. [8] MACISAAC R J, LEE L Y, MCNEIL K J, et al. Influence of age on the presentation and outcome of acidotic and hyperosmolar diabetic emergencies[J]. Intern Med J, 2002, 32(8):379-385. [9] TOKUDA Y, OMATA F, TSUGAWA Y, et al. Vital sign triage to rule out diabetic ketoacidosis and non-ketotic hyperosmolar syndrome in hyperglycemic patients[J]. Diabetes Res Clin Pract, 2010, 87(3):366-371. [10] CHU C H, LEE J K, LAM H C, et al. Prognostic factors of hyperglycemic hyperosmolar nonketotic state[J]. Chang Gung Med J, 2001, 24(6):345-351. [11] THYGESEN K, MAIR J, KATUS H, et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care[J]. Eur Heart J, 2010, 31(18):2197-2204. [12] THYGESEN K, MAIR J, GIANNITSIS E, et al. How to use high-sensitivity cardiac troponins in acute cardiac care[J]. Eur Heart J, 2012, 33(18):2252-2257. [13] THYGESEN K, ALPERT J S, JAFFE A S, et al. Fourth universal definition of myocardial Infarction (2018)[J]. Circulation, 2018, 138(20):e618-e651. [14] MAIR J, LINDAHL B, HAMMARSTEN O, et al. How is cardiac troponin released from injured myocardium?[J]. Eur Heart J Acute Cardiovasc Care, 2018, 7(6):553-560. [15] WHITE H D. Pathobiology of troponin elevations:do elevations occur with myocardial ischemia as well as necrosis?[J]. J Am Coll Cardiol, 2011, 57(24):2406-2408. [16] MAHAJAN N, MEHTA Y, ROSE M, et al. Elevated troponin level is not synonymous with myocardial infarction[J]. Int J Cardiol, 2006, 111(3):442-449. [17] AL-AZZAWI O F N, RAZAK M K A, AL HAMMADY S J.Rhabdomyolysis; is it an overlooked DKA complication[J]. Diabetes Metab Syndr, 2019, 13(5):3047-3052. [18] CRIDDLE L M. Rhabdomyolysis pathophysiology, recognition, and management[J]. Crit Care Nurse, 2003, 23(6):14-22, 24-6, 28 passim; quiz 31-2. [19] SINGHAL P C,ABRAMOVICI M, AYER S,et al. Determinants of rhabdomyolysis in the diabetic state[J]. Am J Nephrol, 1991, 11(6):447-450. [20] TANG Q, LI Z, HUANG D, et al. Continuous renal replacement therapy-the new treatment of seriously hyperglycemia[J]. Am J Emerg Med, 2016, 34(12):2469.e3-2469.e4. [21] 张龙, 范国峰, 张均. 急诊连续性肾脏替代治疗糖尿病非酮症高渗综合征的体会[J]. 内科急危重症杂志, 2012, 18(5):308-313. |